VERU Veru Inc

P/E --
Forward P/E 117.65
Price/Sales 3.11
Beta -1.196
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Veru Inc. trading 11.5% higher, continuing volatile week after Novo Nordisk agreement

Veru Inc. is trading 11.5% up at $3.29, continuing a period of high volatility following a major company announcement earlier in the week. • On June 4, Veru...

🟢 Veru Inc is trading 10.34% up today as it rebounds from a two-day selloff following its Novo Nordisk deal surge

Veru Inc is trading at $3.31 (+10.34%) as it rebounds from a sharp two-day selloff following its June 4 surge tied to the Novo Nordisk supply agreement. • The...

🟢 Veru Inc is trading 5% up today as it rebounds from a sharp pullback following its Novo Nordisk deal surge

Veru Inc is trading at $3.15 (5% up) as it stages a technical rebound following sharp declines that followed its June 4 surge on a Novo Nordisk supply...

🔴 Veru Inc is trading 5.3% down today as it extends a pullback following its recent surge

Veru Inc is trading at $2.84 (-5.33%) in pre-market as the stock continues to pull back from its massive June 4 rally. • The decline follows a period of...

🔴 Veru Inc is trading 11.7% down today as it pulls back from its Novo Nordisk supply agreement surge

Veru Inc is trading 11.7% down at $3.00 as it continues to pull back from a massive surge triggered by its supply agreement with Novo Nordisk. • The stock is...

🔴 Veru Inc is trading 12.6% down today as it extends a pullback following its recent Novo Nordisk deal surge

Veru Inc is trading 12.6% down at $2.97 in pre-market, extending a pullback that followed a massive rally triggered by a clinical trial supply agreement with...

🔴 Veru Inc is trading 5.6% down today on continued profit-taking after Novo Nordisk deal surge

Veru Inc is trading 5.6% down at $3.21 in after-hours trading as investors continue to take profits following a massive rally triggered by its clinical trial...

🔴 Veru Inc is trading 11.8% down today after profit-taking following its Novo Nordisk deal rally

Veru Inc is trading at $3.73 (-11.82%) as the stock undergoes a sharp pullback following a significant rally in the previous session. • The recent surge was...

🔴 Veru Inc is trading 6.9% down today on profit-taking after its Novo Nordisk agreement surge

Veru Inc is trading at $3.94 (6.9% down) as the stock undergoes normalization and profit-taking following an 88% jump driven by its new clinical supply...

Veru Announces Clinical Supply Agreement with Novo Nordisk for Phase 2b Obesity Trial

Veru Announces Clinical Supply Agreement with Novo Nordisk for Phase 2b Obesity Trial

Veru Inc. has entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical study. The study will evaluate the...

Veru Landed a Novo Nordisk Deal and Doubled in a Day — But Can a $60 Million Biotech Sustain the Hype?

Veru Landed a Novo Nordisk Deal and Doubled in a Day — But Can a $60 Million Biotech Sustain the Hype?

Shares of Veru Inc. (VERU) are pulling back 10.4% to $3.79 this morning after an explosive rally that saw the stock surge as much as 161% intraday on...

🔴 Veru Inc is trading 10.4% down today on profit-taking after yesterday's 88% surge from a Novo Nordisk deal

Veru Inc is trading 10.4% down at $3.79 as the stock undergoes consolidation and profit-taking following yesterday's massive 88% rally. • The prior-day surge...

Veru stock surges on Novo Nordisk deal for Wegovy obesity trial

Veru stock surges on Novo Nordisk deal for Wegovy obesity trial

Veru Inc. entered a clinical supply agreement with Novo Nordisk for the Phase 2b PLATEAU trial. Novo Nordisk will provide its weight-loss drug Wegovy...